GT Medical



Rosenman, Showcase, Venture-Backed
GT Medical

GT has developed an innovative approach to the treatment of brain tumors by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™, is protected by 10 issued US patents and has the promise to revolutionize treatment for 175,000 patients/year in the US alone.  At this time, the technology is only available for investigative uses and has not yet received FDA clearance.